MedTrace Logo

PATH-03 Paraguay Feasibility Study

NCT07034092 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-07-17

No results posted yet for this study

Summary

The goal of this study is to evaluate the safety and effectiveness of the ePATH system in the creation of an endovascular AVF (endoAVF) in patients who require or will soon require hemodialysis and are eligible for a fistula.

Conditions

  • Kidney Disease, End-Stage

Interventions

DEVICE

ePATH System will be used to create an endoAVF

An endoAVF will be created in subjects that need fistulas for hemodialysis

Sponsors & Collaborators

  • MINSA SA

    collaborator UNKNOWN

  • Pathfinder Medical

    lead INDUSTRY

Principal Investigators

  • Adrian A Ebner, MD · Sanatorio Italiano

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-06-30
Completion
2026-10-31

Countries

  • Paraguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07034092 on ClinicalTrials.gov